Biotechnology
The Biotechnology industry has a total of 586 stocks, with a combined market cap of $1.23 trillion and total revenue of $110.29 billion.
Market Cap
1.23T
Revenue
110.29B
Profits
-40.39B
PE Ratio
n/a
Profit Margin
-36.62%
Dividend Yield
0.04%
586 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 124.46B | 2.38% | 1,699,354 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 70.73B | 4.20% | 900,062 | 14.92B |
| 3 | ARGX | argenx SE | 55.01B | -1.87% | 293,941 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.09B | -2.24% | 2,393,292 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.51B | 3.60% | 1,437,140 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 36.74B | 1.40% | 257,484 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 34.53B | 2.11% | 3,138,355 | 2.44B |
| 8 | INCY | Incyte Corporation | 25.96B | 9.30% | 5,920,312 | 5.82B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.34B | -2.53% | 4,400,123 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.38B | 1.49% | 664,415 | 3.23B |
| 11 | INSM | Insmed Incorporated | 22.57B | -0.57% | 1,945,266 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 22.14B | 0.31% | 5,552,774 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.75B | 0.69% | 2,212,599 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.77B | 0.40% | 574,818 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.77B | 1.70% | 2,147,283 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 16.14B | 0.58% | 945,152 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.20B | 1.25% | 2,489,288 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.42B | -2.26% | 218,767 | 1.13B |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.08B | 0.29% | 1,694,432 | 622.01M |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.05B | -1.75% | 404,134 | 708.24M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 12.00B | 2.99% | 1,941,980 | 3.24B |
| 22 | TECH | Bio-Techne Corporation | 11.23B | 0.63% | 7,775,616 | 1.21B |
| 23 | CYTK | Cytokinetics, Incorporated | 10.79B | -1.45% | 1,659,986 | 105.82M |
| 24 | KRYS | Krystal Biotech, Inc. | 10.74B | 3.53% | 420,223 | 417.30M |
| 25 | ABVX | ABIVAX Société Anonyme | 10.69B | -2.95% | 1,013,908 | 5.67M |
| 26 | CORT | Corcept Therapeutics Incorporated | 10.11B | 3.37% | 760,727 | 769.10M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.07B | -0.08% | 949,699 | - |
| 28 | SMMT | Summit Therapeutics Inc. | 10.01B | -4.24% | 5,013,104 | - |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.90B | 2.41% | 2,334,097 | 1.51B |
| 30 | IONS | Ionis Pharmaceuticals, Inc. | 9.14B | -1.18% | 2,804,179 | 1.06B |
| 31 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | 0.01% | 2,316,638 | 18.07M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 8.80B | 0.94% | 282,380 | 74.06M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 8.79B | -0.08% | 1,512,208 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 8.73B | -3.53% | 679,738 | 51.48M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.25B | -6.33% | 438,615 | 7.46M |
| 36 | IMVT | Immunovant, Inc. | 8.03B | -2.97% | 897,588 | - |
| 37 | PCVX | Vaxcyte, Inc. | 7.88B | -1.62% | 1,301,551 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.78B | -1.58% | 2,326,041 | 700.35M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.40B | 1.80% | 1,147,400 | 217.17M |
| 40 | IBRX | ImmunityBio, Inc. | 7.30B | -0.29% | 11,843,002 | 140.98M |
| 41 | COGT | Cogent Biosciences, Inc. | 6.95B | 0.57% | 1,133,652 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.84B | -1.73% | 437,933 | 569.61M |
| 43 | CGON | CG Oncology, Inc. | 6.41B | -1.22% | 1,235,817 | 5.07M |
| 44 | ERAS | Erasca, Inc. | 6.30B | -3.76% | 3,816,395 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.28B | -1.28% | 399,414 | 7.50M |
| 46 | PTCT | PTC Therapeutics, Inc. | 6.25B | -0.54% | 1,487,691 | 827.11M |
| 47 | BLTE | Belite Bio, Inc | 6.14B | -1.57% | 119,978 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.92B | 0.90% | 943,467 | - |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | -0.41% | 355,551 | 274.48M |
| 50 | DFTX | Definium Therapeutics, Inc. | 5.57B | -1.62% | 1,948,496 | - |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.55B | -2.76% | 841,020 | 1.34M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.46B | 0.28% | 766,576 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.20B | -1.36% | 1,115,626 | 536.20M |
| 54 | DYN | Dyne Therapeutics, Inc. | 4.83B | 1.05% | 2,334,260 | - |
| 55 | CRSP | CRISPR Therapeutics AG | 4.68B | 1.75% | 2,079,112 | 4.10M |
| 56 | MANE | Veradermics, Incorporated | 4.66B | 0.11% | 970,565 | - |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | 2.44% | 940,669 | 1.10B |
| 58 | CAI | Caris Life Sciences, Inc. | 4.41B | -0.26% | 3,619,431 | 907.29M |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.34B | -3.00% | 963,455 | - |
| 60 | PBLS | Parabilis Medicines, Inc. | 4.07B | 0.44% | 360,838 | - |
| 61 | CELC | Celcuity Inc. | 4.02B | 0.23% | 2,157,387 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 3.99B | -1.88% | 1,596,190 | 10.68M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.93B | -2.90% | 2,085,253 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.85B | -0.26% | 1,714,273 | 56.99M |
| 65 | DNLI | Denali Therapeutics Inc. | 3.82B | 2.04% | 2,106,178 | - |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.75B | 1.94% | 727,195 | - |
| 67 | LEGN | Legend Biotech Corporation | 3.68B | -1.19% | 3,992,784 | 1.14B |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | 3.55B | 2.08% | 1,043,217 | 415.62M |
| 69 | ALMS | Alumis Inc. | 3.45B | -0.18% | 780,173 | 8.40M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 3.44B | -1.66% | 655,269 | 225.27M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.43B | 2.10% | 67,248 | 803.79M |
| 72 | GPCR | Structure Therapeutics Inc. | 3.40B | -1.64% | 507,530 | - |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.40B | -2.84% | 1,579,678 | 236.00M |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | -7.41% | 890,452 | 22.57M |
| 75 | MBX | MBX Biosciences, Inc. | 2.86B | -2.02% | 625,689 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.85B | 0.05% | 448,197 | - |
| 77 | CLDX | Celldex Therapeutics, Inc. | 2.79B | -0.20% | 565,503 | 865.00K |
| 78 | ATAI | AtaiBeckley Inc. | 2.66B | 0.14% | 17,241,106 | 3.49M |
| 79 | IMNM | Immunome, Inc. | 2.63B | 2.83% | 858,914 | 4.02M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.62B | 4.87% | 1,940,722 | 164.01M |
| 81 | TRVI | Trevi Therapeutics, Inc. | 2.62B | 1.71% | 1,666,090 | - |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.55B | -3.38% | 1,814,231 | 670.00M |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 2.54B | -1.95% | 509,531 | 535.08M |
| 84 | QURE | uniQure N.V. | 2.52B | -4.06% | 3,011,060 | 18.09M |
| 85 | KOD | Kodiak Sciences Inc. | 2.52B | -3.87% | 754,792 | - |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.51B | 3.07% | 1,147,860 | 36.77M |
| 87 | VERA | Vera Therapeutics, Inc. | 2.39B | -5.29% | 2,496,538 | - |
| 88 | NKTR | Nektar Therapeutics | 2.39B | -0.81% | 713,140 | 55.63M |
| 89 | VCEL | Vericel Corporation | 2.39B | 3.07% | 349,022 | 292.09M |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -0.96% | 564,754 | - |
| 91 | PHVS | Pharvaris N.V. | 2.36B | -0.96% | 205,060 | - |
| 92 | NUVB | Nuvation Bio Inc. | 2.33B | 0.45% | 5,374,870 | 143.05M |
| 93 | COAG | Hemab Therapeutics Holdings, Inc. | 2.21B | -6.21% | 430,566 | - |
| 94 | KLRA | Kailera Therapeutics, Inc. | 2.17B | -4.23% | 534,132 | - |
| 95 | VRDN | Viridian Therapeutics, Inc. | 2.15B | -0.96% | 924,521 | 70.92M |
| 96 | AGIO | Agios Pharmaceuticals, Inc. | 2.14B | -2.65% | 834,918 | 66.05M |
| 97 | SION | Sionna Therapeutics, Inc. | 2.10B | 2.58% | 320,203 | - |
| 98 | IOVA | Iovance Biotherapeutics, Inc. | 2.10B | -4.08% | 13,430,739 | 285.61M |
| 99 | ZLAB | Zai Lab Limited | 2.09B | -0.11% | 1,136,443 | 453.28M |
| 100 | BHVN | Biohaven Ltd. | 2.07B | -5.10% | 3,623,256 | - |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.07B | -0.67% | 886,058 | 899.11M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.05B | 0.75% | 148,635 | - |
| 103 | ZBIO | Zenas BioPharma, Inc. | 2.04B | -1.61% | 773,056 | 10.00M |
| 104 | ADMA | ADMA Biologics, Inc. | 2.04B | 3.66% | 2,171,893 | 509.86M |
| 105 | RAPP | Rapport Therapeutics, Inc. | 2.01B | -0.39% | 353,947 | 20.00M |
| 106 | URGN | UroGen Pharma Ltd. | 1.99B | -1.40% | 390,300 | 140.49M |
| 107 | SLS | SELLAS Life Sciences Group, Inc. | 1.98B | -6.88% | 10,123,615 | - |
| 108 | PGEN | Precigen, Inc. | 1.97B | 2.03% | 3,429,523 | 31.60M |
| 109 | FTRE | Fortrea Holdings Inc. | 1.96B | 7.81% | 3,237,933 | 2.71B |
| 110 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | -1.71% | 1,497,815 | 298.30M |
| 111 | GHRS | GH Research PLC | 1.92B | 0.76% | 201,985 | - |
| 112 | NBTX | Nanobiotix S.A. | 1.90B | -5.87% | 126,737 | 38.27M |
| 113 | KARD | Kardigan, Inc. | 1.88B | -1.13% | 144,484 | - |
| 114 | FBRX | Forte Biosciences, Inc. | 1.87B | 0.20% | 2,542,942 | - |
| 115 | MESO | Mesoblast Limited | 1.87B | -0.76% | 209,619 | 65.38M |
| 116 | GLUE | Monte Rosa Therapeutics, Inc. | 1.86B | -2.30% | 1,329,704 | 42.95M |
| 117 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 0.07% | 126,806 | 1.20B |
| 118 | OCUL | Ocular Therapeutix, Inc. | 1.85B | -2.20% | 2,373,306 | 52.04M |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.84B | -0.58% | 410,063 | - |
| 120 | STOK | Stoke Therapeutics, Inc. | 1.83B | 0.27% | 598,089 | 32.08M |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.81B | -0.07% | 305,470 | - |
| 122 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.77B | 2.54% | 2,412,771 | 204.73M |
| 123 | BCAX | Bicara Therapeutics Inc. | 1.77B | -3.34% | 489,886 | - |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.75B | -1.44% | 2,557,950 | 7.47M |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -4.34% | 939,059 | 217.17M |
| 126 | IMCR | Immunocore Holdings plc | 1.70B | -0.77% | 207,248 | 412.81M |
| 127 | GENB | Generate Biomedicines, Inc. | 1.68B | -3.95% | 1,456,959 | 30.30M |
| 128 | AAPG | Ascentage Pharma Group International | 1.65B | -3.20% | 4,661 | 82.08M |
| 129 | SRPT | Sarepta Therapeutics, Inc. | 1.63B | -2.89% | 3,002,362 | 2.18B |
| 130 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | 1.33% | 24,323,629 | 66.41M |
| 131 | ZYME | Zymeworks Inc. | 1.62B | -1.70% | 357,503 | 81.26M |
| 132 | ABCL | AbCellera Biologics Inc. | 1.62B | 0.76% | 5,619,464 | 79.21M |
| 133 | INVA | Innoviva, Inc. | 1.61B | 2.39% | 605,766 | 420.69M |
| 134 | MLTX | MoonLake Immunotherapeutics | 1.55B | -5.89% | 1,051,454 | - |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.54B | -2.82% | 383,127 | 20.00M |
| 136 | ANAB | AnaptysBio, Inc. | 1.54B | -2.80% | 521,755 | 232.39M |
| 137 | SEPN | Septerna, Inc. | 1.53B | 1.43% | 263,368 | 72.26M |
| 138 | NTLA | Intellia Therapeutics, Inc. | 1.52B | 2.06% | 4,858,232 | 66.09M |
| 139 | VIR | Vir Biotechnology, Inc. | 1.49B | 0.57% | 1,390,968 | 65.50M |
| 140 | XNCR | Xencor, Inc. | 1.48B | 0.55% | 845,239 | 97.36M |
| 141 | TRAX | First Tracks Biotherapeutics, Inc. | 1.46B | -0.43% | 760,332 | - |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.40B | -0.60% | 818,429 | - |
| 143 | SVRA | Savara Inc. | 1.35B | -1.84% | 1,678,062 | - |
| 144 | AKTS | Aktis Oncology, Inc. | 1.27B | -5.12% | 300,324 | 8.28M |
| 145 | ARDX | Ardelyx, Inc. | 1.26B | 0.49% | 1,655,257 | 427.68M |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.23B | -0.92% | 1,144,801 | - |
| 147 | AVLN | Avalyn Pharma Inc. | 1.23B | 0.62% | 185,080 | - |
| 148 | NVAX | Novavax, Inc. | 1.21B | -1.60% | 2,862,007 | 596.34M |
| 149 | MNKD | MannKind Corporation | 1.21B | -1.01% | 3,644,661 | 360.78M |
| 150 | ABSI | Absci Corporation | 1.21B | -5.69% | 2,540,172 | 1.84M |
| 151 | IMTX | Immatics N.V. | 1.19B | 1.22% | 534,989 | 43.00M |
| 152 | JBIO | Jade Biosciences, Inc. | 1.17B | -1.25% | 775,731 | - |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.17B | -3.36% | 185,892 | 1.30M |
| 154 | WVE | Wave Life Sciences Ltd. | 1.13B | -0.51% | 2,805,555 | 71.80M |
| 155 | CRVS | Corvus Pharmaceuticals, Inc. | 1.12B | 3.02% | 837,603 | - |
| 156 | MGTX | MeiraGTx Holdings plc | 1.09B | -3.90% | 460,755 | 79.76M |
| 157 | VOR | Vor Biopharma Inc. | 1.08B | 2.88% | 757,341 | - |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 1.07B | 0.23% | 572,133 | - |
| 159 | ANRO | Alto Neuroscience, Inc. | 1.07B | -1.61% | 410,266 | - |
| 160 | SPTX | Seaport Therapeutics, Inc. | 1.07B | -3.12% | 75,296 | - |
| 161 | IVA | Inventiva S.A. | 1.06B | 0.87% | 925,943 | 7.94M |
| 162 | DRTS | Alpha Tau Medical Ltd. | 1.04B | -5.41% | 909,154 | - |
| 163 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | 4.93% | 2,678,777 | 69.64M |
| 164 | AVTX | Avalo Therapeutics, Inc. | 1.03B | 0.10% | 815,661 | 59.00K |
| 165 | OLMA | Olema Pharmaceuticals, Inc. | 1.01B | -3.25% | 1,165,677 | - |
| 166 | EYPT | EyePoint, Inc. | 1.00B | -3.63% | 1,697,882 | 7.61M |
| 167 | LBRX | LB Pharmaceuticals Inc | 1.00B | 0.46% | 290,608 | - |
| 168 | SANA | Sana Biotechnology, Inc. | 986.67M | 0.30% | 3,641,704 | - |
| 169 | GERN | Geron Corporation | 930.21M | -2.03% | 5,024,008 | 196.12M |
| 170 | PHAT | Phathom Pharmaceuticals, Inc. | 926.15M | -2.43% | 689,275 | 204.89M |
| 171 | JANX | Janux Therapeutics, Inc. | 914.77M | -3.66% | 684,771 | 13.73M |
| 172 | PHAR | Pharming Group N.V. | 885.23M | -1.18% | 4,235 | 369.49M |
| 173 | ODTX | Odyssey Therapeutics, Inc. | 882.39M | -3.15% | 139,333 | 1.06M |
| 174 | TBPH | Theravance Biopharma, Inc. | 875.38M | 0.18% | 176,857 | 109.78M |
| 175 | ABUS | Arbutus Biopharma Corporation | 871.14M | - | 633,544 | 191.45M |
| 176 | KURA | Kura Oncology, Inc. | 826.49M | -8.28% | 1,468,058 | 71.64M |
| 177 | OMER | Omeros Corporation | 816.39M | -0.53% | 2,222,096 | 9.89M |
| 178 | ANNX | Annexon, Inc. | 814.30M | -3.12% | 2,493,918 | - |
| 179 | TENX | Tenax Therapeutics, Inc. | 807.25M | -2.41% | 1,498,127 | - |
| 180 | DBVT | DBV Technologies S.A. | 799.81M | -2.88% | 365,972 | 5.04M |
| 181 | SLDB | Solid Biosciences Inc. | 784.64M | 1.01% | 1,235,105 | - |
| 182 | AURA | Aura Biosciences, Inc. | 777.61M | -1.54% | 439,328 | - |
| 183 | FTH | Faeth Therapeutics, Inc. | 750.94M | -0.38% | 299,312 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 744.41M | -0.74% | 1,552,966 | 8.37M |
| 185 | DSGN | Design Therapeutics, Inc. | 741.36M | -0.08% | 489,036 | - |
| 186 | MNPR | Monopar Therapeutics Inc. | 730.77M | -1.12% | 528,908 | - |
| 187 | SGP | SpyGlass Pharma, Inc. | 722.83M | 3.84% | 69,789 | - |
| 188 | RIGL | Rigel Pharmaceuticals, Inc. | 712.33M | 2.97% | 142,389 | 299.77M |
| 189 | CADL | Candel Therapeutics, Inc. | 709.26M | -2.81% | 1,664,386 | - |
| 190 | DRUG | Bright Minds Biosciences Inc. | 704.79M | 0.07% | 238,449 | - |
| 191 | CLYM | Climb Bio, Inc. | 703.73M | -3.91% | 935,992 | - |
| 192 | CTMX | CytomX Therapeutics, Inc. | 701.00M | -0.92% | 2,007,571 | 35.54M |
| 193 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 688.12M | -1.83% | 129,179 | - |
| 194 | CBIO | Crescent Biopharma, Inc. | 679.36M | -2.89% | 233,807 | 11.88M |
| 195 | GYRE | Gyre Therapeutics, Inc. | 667.82M | -2.28% | 31,823 | 117.05M |
| 196 | OCS | Oculis Holding AG | 667.59M | 0.32% | 435,868 | 1.40M |
| 197 | NGNE | Neurogene Inc. | 661.97M | -4.04% | 157,389 | 925.00K |
| 198 | MDXG | MiMedx Group, Inc. | 649.40M | 2.35% | 1,119,383 | 389.42M |
| 199 | ACHV | Achieve Life Sciences, Inc. | 634.43M | - | 1,304,648 | - |
| 200 | NVCT | Nuvectis Pharma, Inc. | 624.84M | 1.43% | 195,499 | - |
| 201 | AGMB | AgomAb Therapeutics NV | 617.57M | 0.24% | 33,032 | - |
| 202 | IMMX | Immix Biopharma, Inc. | 600.84M | -2.88% | 1,686,328 | - |
| 203 | RGNX | REGENXBIO Inc. | 592.35M | -1.13% | 1,389,148 | 87.82M |
| 204 | ALT | Altimmune, Inc. | 581.48M | 1.01% | 17,099,868 | 36.00K |
| 205 | CRMD | CorMedix Inc. | 576.62M | -3.29% | 1,127,509 | 400.05M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 575.19M | 0.21% | 1,504,131 | 122.29M |
| 207 | ALLO | Allogene Therapeutics, Inc. | 572.96M | -5.14% | 9,952,217 | 22.00K |
| 208 | SPRY | ARS Pharmaceuticals, Inc. | 563.05M | -1.56% | 1,352,441 | 98.99M |
| 209 | TECX | Tectonic Therapeutic, Inc. | 562.30M | -2.65% | 146,345 | - |
| 210 | MPLT | MapLight Therapeutics, Inc. | 558.21M | 24.28% | 5,537,662 | - |
| 211 | PRME | Prime Medicine, Inc. | 558.11M | 2.66% | 3,092,715 | 4.03M |
| 212 | RLMD | Relmada Therapeutics, Inc. | 548.58M | 0.58% | 1,514,913 | - |
| 213 | VSTM | Verastem, Inc. | 547.45M | 2.47% | 1,273,592 | 49.59M |
| 214 | SLN | Silence Therapeutics plc | 545.55M | -4.31% | 1,239,811 | 839.00K |
| 215 | CTNM | Contineum Therapeutics, Inc. | 529.39M | 2.16% | 210,881 | - |
| 216 | ARVN | Arvinas, Inc. | 529.07M | -0.24% | 551,910 | 89.40M |
| 217 | ZURA | Zura Bio Limited | 526.29M | 2.97% | 504,725 | - |
| 218 | STTK | Shattuck Labs, Inc. | 522.96M | -3.12% | 762,318 | 1.00M |
| 219 | FDMT | 4D Molecular Therapeutics, Inc. | 514.92M | -5.11% | 628,795 | 88.24M |
| 220 | RZLT | Rezolute, Inc. | 513.98M | -0.40% | 980,041 | - |
| 221 | EIKN | Eikon Therapeutics, Inc. | 513.78M | -3.95% | 216,413 | - |
| 222 | ARTV | Artiva Biotherapeutics, Inc. | 511.63M | 2.03% | 355,955 | 251.00K |
| 223 | ANL | Adlai Nortye Ltd. | 507.60M | 5.22% | 200,794 | 5.00M |
| 224 | DNA | Ginkgo Bioworks Holdings, Inc. | 503.00M | 3.36% | 832,543 | 151.40M |
| 225 | ASMB | Assembly Biosciences, Inc. | 492.25M | -1.31% | 86,407 | 71.10M |
| 226 | VALN | Valneva SE | 473.69M | 2.02% | 6,346 | 180.25M |
| 227 | HELP | Cybin Inc. | 471.08M | -1.30% | 860,710 | - |
| 228 | PROK | ProKidney Corp. | 465.17M | - | 788,132 | 889.00K |
| 229 | PRLD | Prelude Therapeutics Incorporated | 460.18M | 19.28% | 1,854,159 | 16.72M |
| 230 | KYTX | Kyverna Therapeutics, Inc. | 455.36M | -5.43% | 1,067,032 | - |
| 231 | IKT | Inhibikase Therapeutics, Inc. | 451.43M | -1.70% | 471,981 | 1.00 |
| 232 | REPL | Replimune Group, Inc. | 449.21M | -38.01% | 23,157,132 | - |
| 233 | SGMT | Sagimet Biosciences Inc. | 448.94M | -2.42% | 392,557 | - |
| 234 | PRTA | Prothena Corporation plc | 448.14M | -1.61% | 802,244 | 57.94M |
| 235 | CABA | Cabaletta Bio, Inc. | 445.14M | 0.37% | 1,882,045 | - |
| 236 | SLBT | SL Science Holding Limited | 444.47M | -0.36% | 38,264 | 3.36M |
| 237 | OVID | Ovid Therapeutics Inc. | 440.47M | 0.43% | 1,351,053 | 7.12M |
| 238 | OCGN | Ocugen, Inc. | 419.77M | -1.59% | 4,632,028 | 4.47M |
| 239 | BNTC | Benitec Biopharma Inc. | 408.47M | 2.68% | 77,899 | - |
| 240 | PBYI | Puma Biotechnology, Inc. | 405.67M | -0.25% | 310,476 | 227.18M |
| 241 | EVMN | Evommune, Inc. | 405.21M | -1.92% | 689,859 | 10.00M |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 404.59M | -1.13% | 511,787 | - |
| 243 | EDIT | Editas Medicine, Inc. | 402.07M | -2.24% | 1,301,791 | 38.69M |
| 244 | LRMR | Larimar Therapeutics, Inc. | 399.79M | - | 1,778,405 | - |
| 245 | STRO | Sutro Biopharma, Inc. | 393.22M | -1.17% | 245,675 | 99.61M |
| 246 | CCCC | C4 Therapeutics, Inc. | 392.51M | -1.11% | 2,358,985 | 34.86M |
| 247 | AUTL | Autolus Therapeutics plc | 385.91M | -0.68% | 527,206 | 92.62M |
| 248 | VTVT | vTv Therapeutics Inc. | 385.69M | 0.19% | 101,063 | 36.84M |
| 249 | CAPR | Capricor Therapeutics, Inc. | 380.48M | -6.08% | 16,421,269 | 11.13M |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 370.68M | -0.25% | 861,231 | 9.01M |
| 251 | IPSC | Century Therapeutics, Inc. | 369.73M | -1.91% | 857,858 | 109.16M |
| 252 | CMPX | Compass Therapeutics, Inc. | 367.38M | -1.92% | 3,146,146 | 850.00K |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 366.68M | -0.94% | 177,277 | 69.21M |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 360.92M | -6.43% | 1,392,415 | - |
| 255 | DMAC | DiaMedica Therapeutics Inc. | 357.79M | -1.48% | 206,697 | - |
| 256 | PALI | Palisade Bio, Inc. | 350.63M | -0.49% | 2,049,735 | - |
| 257 | UPB | Upstream Bio, Inc. | 348.29M | - | 432,761 | 3.32M |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 345.29M | -2.64% | 82,921 | 51.00M |
| 259 | CUVL | Clinuvel Pharmaceuticals Limited | 345.17M | - | 44 | 64.24M |
| 260 | LXEO | Lexeo Therapeutics, Inc. | 344.71M | -1.79% | 586,092 | - |
| 261 | ABEO | Abeona Therapeutics Inc. | 343.11M | -1.79% | 862,227 | 14.54M |
| 262 | RCKT | Rocket Pharmaceuticals, Inc. | 342.87M | -3.38% | 1,541,205 | - |
| 263 | SCTX | Scribe Therapeutics Inc. | 340.69M | -4.80% | 428,431 | 36.28M |
| 264 | ZNTL | Zentalis Pharmaceuticals, Inc. | 328.88M | 2.44% | 1,212,993 | 26.87M |
| 265 | VCRE | Vicore Pharma Holding AB (publ) | 321.73M | 1.99% | 1,711 | 370.61K |
| 266 | LYEL | Lyell Immunopharma, Inc. | 318.31M | 0.23% | 157,077 | 31.00K |
| 267 | NMRA | Neumora Therapeutics, Inc. | 311.28M | 1.20% | 676,942 | - |
| 268 | VNDA | Vanda Pharmaceuticals Inc. | 310.30M | -1.15% | 541,331 | 217.78M |
| 269 | FHTX | Foghorn Therapeutics Inc. | 301.20M | -1.35% | 159,618 | 28.22M |
| 270 | AGEN | Agenus Inc. | 295.37M | 7.67% | 2,771,365 | 123.87M |
| 271 | OABI | OmniAb, Inc. | 285.60M | -2.96% | 312,950 | 28.94M |
| 272 | IRD | Opus Genetics, Inc. | 281.55M | 1.79% | 669,781 | 11.98M |
| 273 | BCYC | Bicycle Therapeutics plc | 275.06M | -0.25% | 320,845 | 63.50M |
| 274 | IMRX | Immuneering Corporation | 274.32M | -2.75% | 667,385 | - |
| 275 | SLGL | Sol-Gel Technologies Ltd. | 271.56M | 4.06% | 53,145 | 18.47M |
| 276 | FATE | Fate Therapeutics, Inc. | 270.42M | -4.53% | 1,766,516 | 6.32M |
| 277 | ALXO | ALX Oncology Holdings Inc. | 267.78M | -1.49% | 328,438 | - |
| 278 | LCTX | Lineage Cell Therapeutics, Inc. | 266.75M | 3.88% | 891,169 | 14.78M |
| 279 | QTTB | Q32 Bio Inc. | 266.39M | 3.29% | 536,109 | 53.74M |
| 280 | SABS | SAB Biotherapeutics, Inc. | 263.80M | 0.29% | 241,238 | 114.70K |
| 281 | ELDN | Eledon Pharmaceuticals, Inc. | 262.83M | -4.76% | 1,520,362 | - |
| 282 | NAGE | Niagen Bioscience, Inc. | 262.58M | 1.86% | 518,200 | 130.42M |
| 283 | IFRX | InflaRx N.V. | 248.92M | -0.59% | 1,181,504 | 33.82K |
| 284 | PRQR | ProQR Therapeutics N.V. | 248.37M | 1.73% | 494,881 | 15.73M |
| 285 | FULC | Fulcrum Therapeutics, Inc. | 247.88M | -0.27% | 1,204,517 | 80.00M |
| 286 | ADAG | Adagene Inc. | 246.45M | 5.67% | 415,804 | 7.67M |
| 287 | MGNX | MacroGenics, Inc. | 244.72M | -3.75% | 874,967 | 157.08M |
| 288 | AVXL | Anavex Life Sciences Corp. | 238.17M | 2.80% | 775,980 | - |
| 289 | OBIO | Orchestra BioMed Holdings, Inc. | 231.14M | 1.05% | 194,383 | 32.72M |
| 290 | ACIU | AC Immune SA | 230.15M | 0.87% | 104,134 | 4.62M |
| 291 | TTRX | Turn Therapeutics Inc. | 229.37M | -1.03% | 46,162 | - |
| 292 | SRZN | Surrozen, Inc. | 225.24M | -2.07% | 458,902 | 7.49M |
| 293 | RNAC | Cartesian Therapeutics, Inc. | 224.77M | -1.80% | 106,228 | 1.78M |
| 294 | GALT | Galectin Therapeutics Inc. | 223.25M | 0.30% | 259,276 | - |
| 295 | CHRS | Coherus Oncology, Inc. | 222.12M | -1.37% | 387,624 | 46.88M |
| 296 | TARA | Protara Therapeutics, Inc. | 221.44M | -2.48% | 371,552 | - |
| 297 | CGEN | Compugen Ltd. | 213.76M | -5.04% | 179,048 | 72.66M |
| 298 | TRDA | Entrada Therapeutics, Inc. | 210.08M | -4.11% | 374,952 | 5.74M |
| 299 | CNXU | Conexeu Sciences Inc. | 208.45M | 1.43% | 78,617 | - |
| 300 | CLLS | Cellectis S.A. | 207.98M | -1.73% | 15,458 | 75.11M |
| 301 | NBP | NovaBridge Biosciences | 202.38M | -1.69% | 247,682 | - |
| 302 | NERV | Minerva Neurosciences, Inc. | 199.40M | 1.78% | 199,222 | - |
| 303 | KROS | Keros Therapeutics, Inc. | 199.30M | -1.37% | 163,345 | 33.18M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 197.92M | -0.54% | 530,736 | 7.15M |
| 305 | GLSI | Greenwich LifeSciences, Inc. | 197.42M | 0.07% | 161,785 | - |
| 306 | RNA | Atrium Therapeutics, Inc. | 196.54M | -0.69% | 91,911 | 36.68M |
| 307 | INDP | Indaptus Therapeutics, Inc. | 195.91M | -15.20% | 160,006 | - |
| 308 | MDWD | MediWound Ltd. | 187.90M | 1.18% | 46,084 | 14.48M |
| 309 | PLX | Protalix BioTherapeutics, Inc. | 187.73M | -2.92% | 381,881 | 76.38M |
| 310 | DTIL | Precision BioSciences, Inc. | 185.00M | -1.10% | 179,621 | 45.07M |
| 311 | PYXS | Pyxis Oncology, Inc. | 184.36M | - | 1,723,817 | 13.86M |
| 312 | LENZ | LENZ Therapeutics, Inc. | 184.36M | 3.16% | 639,306 | 20.99M |
| 313 | VYGR | Voyager Therapeutics, Inc. | 183.68M | -1.62% | 489,576 | 36.49M |
| 314 | ACOG | Alpha Cognition Inc. | 183.12M | -1.98% | 111,349 | 10.83M |
| 315 | IMUX | Immunic, Inc. | 181.71M | -3.40% | 103,094 | - |
| 316 | CAMP | Camp4 Therapeutics Corporation | 177.59M | - | 99,310 | 3.93M |
| 317 | MENS | Jyong Biotech Ltd. | 177.42M | -1.65% | 86,984 | - |
| 318 | IVVD | Invivyd, Inc. | 174.79M | -2.72% | 2,667,191 | 55.87M |
| 319 | ARMP | Armata Pharmaceuticals, Inc. | 173.64M | -8.16% | 59,114 | 5.20M |
| 320 | IPHA | Innate Pharma S.A. | 173.08M | -5.17% | 5,182 | 10.57M |
| 321 | NGEN | NervGen Pharma Corp. | 171.32M | -1.83% | 385,168 | - |
| 322 | ORMP | Oramed Pharmaceuticals Inc. | 170.66M | 0.24% | 112,702 | 2.00M |
| 323 | HUMA | Humacyte, Inc. | 170.06M | -6.44% | 2,216,722 | 2.02M |
| 324 | ANTX | AN2 Therapeutics, Inc. | 169.28M | -4.67% | 93,811 | - |
| 325 | OTLK | Outlook Therapeutics, Inc. | 169.05M | -15.12% | 34,038,652 | 333.14K |
| 326 | ALEC | Alector, Inc. | 168.76M | 0.66% | 342,672 | 18.42M |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 168.33M | 0.06% | 154,941 | - |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 164.68M | 3.64% | 854,281 | - |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 164.07M | -1.75% | 1,434,599 | 225.00K |
| 330 | ARCT | Arcturus Therapeutics Holdings Inc. | 163.43M | -0.17% | 347,890 | 54.71M |
| 331 | YDES | YD Bio Limited | 161.74M | 0.44% | 42,619 | 510.36K |
| 332 | ENTX | Entera Bio Ltd. | 160.69M | -16.84% | 5,249,061 | 42.00K |
| 333 | KPTI | Karyopharm Therapeutics Inc. | 160.68M | - | 531,284 | 151.12M |
| 334 | OKUR | OnKure Therapeutics, Inc. | 159.56M | -2.47% | 96,538 | - |
| 335 | NKTX | Nkarta, Inc. | 158.83M | -1.77% | 592,102 | - |
| 336 | TNXP | Tonix Pharmaceuticals Holding Corp. | 158.45M | -4.15% | 451,240 | 17.56M |
| 337 | CNTN | Canton Strategic Holdings, Inc. | 157.33M | 0.49% | 597,063 | - |
| 338 | NAUT | Nautilus Biotechnology, Inc. | 152.49M | -27.71% | 2,084,194 | 190.00K |
| 339 | KRRO | Korro Bio, Inc. | 151.44M | -2.05% | 153,986 | 3.84M |
| 340 | MOLN | Molecular Partners AG | 148.52M | -4.36% | 435 | 856.30K |
| 341 | NRXP | NRx Pharmaceuticals, Inc. | 148.36M | -2.48% | 996,634 | 2.29M |
| 342 | CBUS | Cibus, Inc. | 148.08M | 7.18% | 151,420 | 4.29M |
| 343 | CRBU | Caribou Biosciences, Inc. | 147.78M | -6.29% | 1,959,189 | 11.20M |
| 344 | EQ | Equillium, Inc. | 146.69M | -5.69% | 966,516 | 4.39M |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 145.57M | -5.31% | 2,566,954 | 1.78M |
| 346 | KZIA | Kazia Therapeutics Limited | 145.01M | 3.93% | 201,351 | 1.27M |
| 347 | AARD | Aardvark Therapeutics, Inc. | 140.06M | -4.04% | 53,213 | - |
| 348 | CDXS | Codexis, Inc. | 136.34M | -3.23% | 1,514,347 | 78.09M |
| 349 | HURA | TuHURA Biosciences, Inc. | 135.64M | -3.62% | 213,799 | - |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 135.32M | -3.70% | 1,006,961 | - |
| 351 | CNTB | Connect Biopharma Holdings Limited | 130.96M | -0.95% | 216,024 | 233.00K |
| 352 | PMN | ProMIS Neurosciences, Inc. | 130.21M | 23.89% | 1,771,921 | - |
| 353 | GNLX | Genelux Corporation | 129.67M | -1.02% | 145,452 | 8.00K |
| 354 | CUE | Cue Biopharma, Inc. | 127.06M | -7.12% | 202,150 | 32.73M |
| 355 | PEPG | PepGen Inc. | 126.58M | -3.68% | 604,123 | - |
| 356 | TLSA | Tiziana Life Sciences Ltd | 125.07M | 6.26% | 253,607 | - |
| 357 | ANIX | Anixa Biosciences, Inc. | 119.76M | 1.73% | 297,708 | - |
| 358 | ENGN | enGene Therapeutics Inc. | 117.90M | - | 582,859 | - |
| 359 | SEER | Seer, Inc. | 117.66M | 8.63% | 5,497,988 | 15.17M |
| 360 | GUTS | Fractyl Health, Inc. | 114.64M | -9.79% | 2,699,841 | 3.00K |
| 361 | SPRB | Spruce Biosciences, Inc. | 114.49M | -0.93% | 63,150 | 697.00K |
| 362 | VANI | Vivani Medical, Inc. | 112.97M | 0.77% | 218,338 | - |
| 363 | FBIO | Fortress Biotech, Inc. | 112.61M | 3.67% | 402,399 | 66.16M |
| 364 | ICCC | ImmuCell Corporation | 101.69M | 0.99% | 8,688 | 29.93M |
| 365 | RANI | Rani Therapeutics Holdings, Inc. | 101.50M | 1.14% | 341,009 | 3.17M |
| 366 | GOSS | Gossamer Bio, Inc. | 100.26M | 2.86% | 208,763,034 | 55.54M |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 99.13M | 1.73% | 1,059,184 | 70.00M |
| 368 | PTHS | Pelthos Therapeutics Inc. | 96.52M | 0.65% | 103,872 | 27.70M |
| 369 | ALDX | Aldeyra Therapeutics, Inc. | 95.31M | -0.32% | 916,756 | - |
| 370 | ONCY | Oncolytics Biotech Inc. | 94.54M | -1.00% | 826,001 | - |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 94.21M | 1.53% | 78,009 | - |
| 372 | COYA | Coya Therapeutics, Inc. | 93.83M | -6.21% | 203,193 | 7.94M |
| 373 | VRCA | Verrica Pharmaceuticals Inc. | 92.77M | 0.93% | 48,756 | 37.16M |
| 374 | HRTX | Heron Therapeutics, Inc. | 91.97M | 5.81% | 1,618,662 | 150.71M |
| 375 | NTHI | NeOnc Technologies Holdings, Inc. | 90.51M | 1.45% | 52,848 | 39.99K |
| 376 | BMEA | Biomea Fusion, Inc. | 90.37M | -0.79% | 695,189 | - |
| 377 | ACET | Adicet Bio, Inc. | 86.11M | 1.74% | 54,729 | - |
| 378 | OKYO | OKYO Pharma Limited | 86.07M | - | 84,919 | - |
| 379 | RLYB | Rallybio Corporation | 85.59M | -0.95% | 25,319 | 858.00K |
| 380 | INO | Inovio Pharmaceuticals, Inc. | 84.74M | 6.72% | 990,991 | 65.34K |
| 381 | CGTX | Cognition Therapeutics, Inc. | 82.65M | -2.73% | 468,624 | - |
| 382 | TELO | Telomir Pharmaceuticals, Inc. | 81.15M | -4.07% | 119,831 | - |
| 383 | NRXS | NeurAxis, Inc. | 80.87M | -3.12% | 90,799 | 4.28M |
| 384 | ATHE | Alterity Therapeutics Limited | 80.63M | -2.14% | 2,077 | 4.43M |
| 385 | KLRS | Kalaris Therapeutics, Inc. | 79.47M | -6.70% | 118,210 | - |
| 386 | ALPS | Alps Group Inc | 77.44M | -0.47% | 52,916 | 3.74M |
| 387 | CSBR | Champions Oncology, Inc. | 76.83M | -8.75% | 30,920 | 59.43M |
| 388 | MAIA | MAIA Biotechnology, Inc. | 75.39M | -3.13% | 517,394 | - |
| 389 | GANX | Gain Therapeutics, Inc. | 73.79M | -6.99% | 325,166 | - |
| 390 | RNTX | Rein Therapeutics Inc. | 72.74M | 0.03% | 833,908 | - |
| 391 | PYPD | PolyPid Ltd. | 71.90M | -5.78% | 129,351 | - |
| 392 | ANVS | Annovis Bio, Inc. | 71.90M | 1.20% | 718,784 | - |
| 393 | ATRA | Atara Biotherapeutics, Inc. | 70.37M | 1.30% | 85,279 | 23.14M |
| 394 | XBIT | XBiotech Inc. | 69.21M | 0.44% | 16,367 | - |
| 395 | SPRO | Spero Therapeutics, Inc. | 69.19M | 1.27% | 1,602,355 | 61.19M |
| 396 | ELTX | Elicio Therapeutics, Inc. | 69.18M | -1.67% | 361,239 | - |
| 397 | IBIO | iBio, Inc. | 69.05M | -4.14% | 1,013,400 | 300.00K |
| 398 | OSTX | OS Therapies Incorporated | 66.81M | -1.96% | 290,053 | - |
| 399 | PLRX | Pliant Therapeutics, Inc. | 66.25M | -0.93% | 358,710 | - |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 65.91M | -1.28% | 234,956 | - |
| 401 | LONA | LeonaBio, Inc. | 65.47M | -5.30% | 19,817 | - |
| 402 | MNOV | MediciNova, Inc. | 65.46M | 0.76% | 57,966 | 596.64K |
| 403 | IMA | ImageneBio, Inc. | 64.97M | 2.86% | 3,593 | 800.00K |
| 404 | HYFT | MindWalk Holdings Corp. | 63.53M | -5.56% | 154,525 | 11.43M |
| 405 | CING | Cingulate Inc. | 61.01M | 0.22% | 238,914 | - |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 58.66M | -6.78% | 471,974 | - |
| 407 | CRDF | Cardiff Oncology, Inc. | 55.93M | -2.14% | 1,118,564 | 525.00K |
| 408 | BOLD | Boundless Bio, Inc. | 55.48M | -0.40% | 137,850 | - |
| 409 | XLO | Xilio Therapeutics, Inc. | 54.74M | 0.66% | 47,203 | 53.48M |
| 410 | CNTX | Context Therapeutics Inc. | 54.26M | -5.09% | 2,135,080 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 52.51M | -0.47% | 6,766 | - |
| 412 | DWTX | Dogwood Therapeutics, Inc. | 52.13M | 1.31% | 36,566 | - |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.71M | 5.78% | 22,346 | - |
| 414 | TCRX | TScan Therapeutics, Inc. | 50.58M | 0.74% | 704,745 | 9.14M |
| 415 | VRXA | Veraxa Biotech AG | 49.93M | -1.49% | 309,868 | - |
| 416 | TIL | Instil Bio, Inc. | 49.44M | 1.96% | 7,766 | - |
| 417 | MREO | Mereo BioPharma Group plc | 49.39M | 2.42% | 1,718,083 | 500.00K |
| 418 | BYSI | BeyondSpring Inc. | 48.73M | 1.28% | 6,585 | 1.88M |
| 419 | IMMP | Immutep Limited | 48.44M | 0.89% | 110,453 | 5.28M |
| 420 | ATYR | aTyr Pharma, Inc. | 48.44M | 0.90% | 900,234 | 190.00K |
| 421 | MCRB | Seres Therapeutics, Inc. | 46.48M | -1.03% | 63,361 | 1.15M |
| 422 | IBO | Impact BioMedical Inc. | 46.36M | -0.46% | 14,205 | 39.00K |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | - | 109,072 | 22.33M |
| 424 | INMB | INmune Bio Inc. | 45.46M | -1.16% | 130,824 | 50.00K |
| 425 | EDSA | Edesa Biotech, Inc. | 44.19M | -7.10% | 83,702 | - |
| 426 | FLNA | Filana Therapeutics, Inc. | 42.75M | -1.72% | 165,700 | - |
| 427 | RNXT | RenovoRx, Inc. | 40.92M | -5.99% | 219,740 | 1.49M |
| 428 | APLM | Apollomics, Inc. | 40.01M | 1.22% | 5,761 | 8.84M |
| 429 | DYAI | Dyadic International, Inc. | 38.63M | -6.19% | 353,272 | 3.81M |
| 430 | PDSB | PDS Biotechnology Corporation | 38.55M | -0.30% | 75,980 | - |
| 431 | BIOT | Instinct Brothers Co., Ltd. | 38.33M | -51.46% | 2,218,360 | - |
| 432 | EXOZ | eXoZymes, Inc. | 37.31M | -3.30% | 7,478 | -700.00 |
| 433 | RADX | Radiopharm Theranostics Limited | 37.09M | -9.56% | 164,770 | 10.86M |
| 434 | GNTA | Genenta Science S.p.A. | 37.04M | -1.26% | 98,254 | - |
| 435 | HYPD | Hyperion DeFi, Inc. | 36.68M | -5.47% | 236,881 | 1.04M |
| 436 | NNVC | NanoViricides, Inc. | 36.68M | 4.55% | 623,303 | - |
| 437 | GRCE | Grace Therapeutics, Inc. | 36.29M | -2.17% | 517,908 | - |
| 438 | ENLV | Enlivex Ltd. | 36.00M | -47.42% | 3,971,647 | - |
| 439 | NTRB | Nutriband Inc. | 35.92M | -0.84% | 1,792 | 1.80M |
| 440 | VERU | Veru Inc. | 35.79M | -2.19% | 197,746 | 16.89M |
| 441 | CRVO | CervoMed Inc. | 34.63M | -3.76% | 411,665 | 2.09M |
| 442 | LTRN | Lantern Pharma Inc. | 33.17M | -6.81% | 64,935 | - |
| 443 | LITS | Lite Strategy, Inc. | 33.00M | -0.67% | 97,157 | - |
| 444 | ESLA | Estrella Immunopharma, Inc. | 32.21M | -3.39% | 24,598 | - |
| 445 | BCTX | BriaCell Therapeutics Corp. | 31.07M | -2.25% | 50,923 | - |
| 446 | SER | Serina Therapeutics, Inc. | 31.04M | -1.43% | 27,739 | 130.00K |
| 447 | KYNB | Kyntra Bio, Inc. | 28.24M | -1.06% | 8,922 | 7.44M |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 27.19M | 1.42% | 72,397 | 90.00K |
| 449 | ABVC | ABVC BioPharma, Inc. | 26.79M | 3.92% | 59,250 | 797.92K |
| 450 | ALGS | Aligos Therapeutics, Inc. | 26.30M | 4.17% | 87,482 | 4.71M |
| 451 | IGC | IGC Pharma, Inc. | 25.92M | -1.52% | 314,226 | 1.11M |
| 452 | PSTV | Plus Therapeutics, Inc. | 25.88M | 0.80% | 54,485 | 5.18M |
| 453 | ACTU | Actuate Therapeutics, Inc. | 25.36M | -7.83% | 214,385 | - |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 23.59M | 0.36% | 22,494 | - |
| 455 | EVAX | Evaxion A/S | 23.35M | -3.11% | 21,164 | 7.53M |
| 456 | BRNS | Barinthus Biotherapeutics plc | 23.28M | -5.16% | 6,021 | 14.97M |
| 457 | TVRD | Tvardi Therapeutics, Inc. | 22.89M | -3.94% | 546,230 | - |
| 458 | CELU | Celularity Inc. | 22.00M | 1.21% | 18,094 | 26.55M |
| 459 | HOWL | Werewolf Therapeutics, Inc. | 21.83M | -0.88% | 302,603 | 1.14M |
| 460 | SKYE | Skye Bioscience, Inc. | 21.61M | -1.27% | 191,999 | - |
| 461 | PLRZ | Polyrizon Ltd. | 21.08M | -19.80% | 88,288 | - |
| 462 | CVM | CEL-SCI Corporation | 20.97M | 1.69% | 144,074 | - |
| 463 | ATOS | Atossa Therapeutics, Inc. | 20.80M | 2.33% | 45,902 | - |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 20.59M | -1.04% | 97,085 | -13.27K |
| 465 | CLRB | Cellectar Biosciences, Inc. | 19.98M | 3.31% | 50,786 | - |
| 466 | GRDX | GridAI Technologies Corp. | 19.89M | -5.08% | 48,331 | - |
| 467 | NRSN | NeuroSense Therapeutics Ltd. | 19.74M | -4.89% | 504,055 | - |
| 468 | MRKR | Marker Therapeutics, Inc. | 19.67M | -3.28% | 20,189 | 3.55M |
| 469 | NXTC | NextCure, Inc. | 19.58M | 5.86% | 230,290 | - |
| 470 | LGVN | Longeveron Inc. | 19.00M | -1.56% | 72,227 | 1.22M |
| 471 | QNCX | Quince Therapeutics, Inc. | 18.94M | 8.52% | 37,606 | - |
| 472 | ALLR | Allarity Therapeutics, Inc. | 18.77M | -4.07% | 81,890 | 345.00K |
| 473 | NCEL | NewcelX Ltd. | 18.74M | -3.33% | 9,272 | - |
| 474 | QNTM | Quantum BioPharma Ltd. | 18.17M | 1.01% | 48,822 | - |
| 475 | PLUR | Pluri Inc. | 18.13M | 2.44% | 8,629 | 1.08M |
| 476 | DARE | Daré Bioscience, Inc. | 17.75M | -10.23% | 167,359 | 1.16M |
| 477 | JSPR | Jasper Therapeutics, Inc. | 17.72M | -8.83% | 530,941 | - |
| 478 | LPCN | Lipocine Inc. | 17.64M | - | 32,036 | 2.00M |
| 479 | PTN | Palatin Technologies, Inc. | 17.10M | -1.66% | 6,805 | 12.88M |
| 480 | OSRH | OSR Health, Inc. | 16.03M | 5.43% | 275,620 | 2.63M |
| 481 | MLEC | Moolec Science SA | 15.11M | -1.33% | 9,357 | 7.83M |
| 482 | KTTA | Pasithea Therapeutics Corp. | 15.04M | - | 232,475 | - |
| 483 | CYCN | Cyclerion Therapeutics, Inc. | 14.84M | - | 18,507 | 1.99M |
| 484 | AKTX | Akari Therapeutics, Plc | 14.76M | -0.35% | 29,054 | - |
| 485 | PASG | Passage Bio, Inc. | 14.66M | -1.08% | 15,029 | - |
| 486 | HIND | Vyome Holdings, Inc. | 13.97M | -0.50% | 10,048 | 152.72K |
| 487 | ICU | SeaStar Medical Holding Corporation | 13.83M | -3.64% | 39,871 | 1.44M |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 13.67M | -3.64% | 311,580 | 5.61M |
| 489 | LEXX | Lexaria Bioscience Corp. | 13.39M | 3.57% | 45,246 | 194.00K |
| 490 | TPST | Tempest Therapeutics, Inc. | 12.90M | -6.81% | 146,783 | - |
| 491 | COCP | Cocrystal Pharma, Inc. | 12.89M | 1.76% | 16,698 | 225.00K |
| 492 | BLRX | BioLineRx Ltd. | 12.89M | -0.25% | 15,946 | 1.40M |
| 493 | INTS | Intensity Therapeutics, Inc. | 12.30M | -0.44% | 29,950 | - |
| 494 | KALA | KALA BIO, Inc. | 12.27M | -1.55% | 45,086 | - |
| 495 | PBM | Psyence Biomedical Ltd. | 12.05M | 3.95% | 50,663 | - |
| 496 | SNTI | Senti Biosciences Holdings, Inc. | 11.88M | 2.14% | 145,346 | 38.00K |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 11.73M | -3.81% | 117,554 | - |
| 498 | MBRX | Moleculin Biotech, Inc. | 11.69M | - | 105,545 | - |
| 499 | GTBP | GT Biopharma, Inc. | 11.42M | -5.21% | 467,903 | - |
| 500 | KPRX | Kiora Pharmaceuticals, Inc. | 11.39M | 1.18% | 13,100 | 20.00K |